Structure Therapeutics Inc. - Rasio total nilai perusahaan marang pendapatan GPCR

Structure Therapeutics Inc (GPCR) - logo korporat

The change in the EV/Sales multiple demonstrates the valuation dynamics of Structure Therapeutics (GPCR), where 0.00 expresses the current value of the metric. Share prices depend on the results of new drug trials rather than fundamentals. Production is based on outsourcing via CMO plants. High confidence within the scientific community regarding innovations in the fight against obesity fosters a positive brand image.

GPCR Structure Therapeutics: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 19.11.2026

Rincian metrik keuangan lan pasar Structure Therapeutics Inc. (GPCR)

Analisis wiwitan perusahaan:Structure Therapeutics Inc. GPCR
Produk asli structuretx.com

The metric is calculated as the ratio of total enterprise value, including debt and cash, to annual sales volume. This metric determines the market value of each dollar of revenue, ignoring financing specifics. For Structure Therapeutics (GPCR), the calculation reflects inflated expectations for future anti-obesity drugs. The current business does not yet generate commercial revenue, making the EV/Sales valuation an indicator of a speculative premium. The trend in this EV/Sales valuation illustrates the market's willingness to pay a premium for the potential success of clinical trials.

Pesaing langsung

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)